Polycystic ovary syndrome is a common endocrine disorder in women of reproductive age, characterized by chronic anovulation and hyperandrogenemia. The hormone panel alone cannot determine polycystic ovarian syndrome, which can only be determined after combining the patient’s symptoms, ultrasound performance and excluding endocrine diseases such as hyperprolactinemia, pituitary tumor, adrenal cortical hyperplasia, ovarian tumor and thyroid abnormalities. 1.How to determine ovarian polycystic 1.Hormone 6 includes estradiol (E2), progesterone (P), testosterone (T), prolactin (PRL), luteinizing hormone (LH), follicle stimulating hormone (FSH). To diagnose polycystic ovaries by sex hormone panel, the main findings are as follows: (1) elevated serum testosterone; (2) normal or low folliculopoietin, elevated luteinizing hormone, luteinizing hormone to folliculopoietin ratio >2; (3) 20% of polycystic patients may have elevated serum lactogen. If the hormone level is abnormal, and there are also clinical manifestations of high androgens, such as hirsutism, then polycystic ovary syndrome can be suspected. (1) Menstrual disorders: scanty menstruation, amenorrhea, and functional uterine bleeding in a few cases. (4) Ancillary examinations: ultrasound shows polycystic ovaries. (4) Auxiliary examination: ultrasound shows polycystic ovarian changes. Treatment of polycystic ovary syndrome 1. General treatment: mainly for obese patients, strengthening exercise and diet control can help restore ovulation and fertility function; 2.